Luxbright AB (LXB) AI Stock Analysis

• Market Cap: kr96.24M
• Dividend Yield: N/A
• Average Volume (3M): 89.34K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.02
• Revenue Growth: 955.20%
• EPS Growth: 47.31%
• Country: SE
• Employees: 10
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Devices
• EPS (TTM): -0.07
• Shares Outstanding: 131,468,980
• 10 Day Avg. Volume: 130,926
• 30 Day Avg. Volume: 89,345
• PEG Ratio: 0.24
• Price to Book (P/B): 2.10
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.83
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 37 Underperform
• Price Target: ―

Luxbright AB faces significant financial challenges, including ongoing losses and negative cash flows, which pose high financial risk. The technical indicators show a bearish trend, and the absence of profitability impacts valuation negatively. Overall, the stock's outlook is cautious, with a need for strategic improvements to enhance its financial and operational standing.

Luxbright AB Business Overview & Revenue Model

Company Description

Luxbright AB (LXB) is a Sweden-based company that operates in the medical technology sector. The company specializes in the development and manufacturing of innovative X-ray tubes and generators, which are utilized in various applications including healthcare, security, and industrial inspection. Luxbright is dedicated to advancing X-ray technology with its proprietary cold cathode technology, which aims to enhance image quality and reduce radiation exposure.

How the Company Makes Money

Luxbright AB generates revenue by designing, producing, and selling its advanced X-ray tubes and systems to clients in the healthcare, security, and industrial sectors. The company capitalizes on its unique cold cathode technology, which offers enhanced performance and safety features compared to traditional X-ray systems, attracting a variety of customers looking for cutting-edge solutions. Luxbright may also form strategic partnerships or licensing agreements to expand its market reach and further monetize its proprietary technology. Additionally, the company might receive income from research collaborations and grants aimed at advancing its technological innovations.

Luxbright AB Financial Statement Overview

Summary

Luxbright AB is in a challenging financial position with ongoing losses, despite revenue growth and a strong equity base. The lack of profitability and negative cash flows suggest high financial risk, which may require strategic adjustments to enhance operational efficiency and financial performance.

Income Statement

Luxbright AB has shown significant revenue growth in the most recent year, but the company remains unprofitable with negative EBIT and net income over the past years. The gross profit margin is high at 98.4% for 2024, but the net profit margin is negative due to high operating expenses. The continuous losses are a significant concern despite revenue growth.

Balance Sheet

The company has a strong equity position with no debt, resulting in a debt-to-equity ratio of zero. However, the return on equity (ROE) remains negative due to continued net losses. The equity ratio is stable, showing a solid foundation, but profitability issues weigh on the overall balance sheet health.

Cash Flow

Luxbright AB's operating cash flow and free cash flow are consistently negative, indicating cash burn. The financing cash flow has been positive, suggesting reliance on external funding. The free cash flow to net income ratio is not favorable, highlighting a need for improved cash generation from operations.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
9.02M	854.70K	811.70K	729.00K	614.29K
	Gross Profit
8.88M	-2.80M	189.12K	1.98M	1.57M
	EBIT
-18.06M	-25.80M	-21.52M	-17.91M	-12.29M
	EBITDA
-15.72M	-24.35M	-20.47M	-17.63M	-12.18M
	Net Income Common Stockholders
-17.72M	-25.38M	-21.13M	-18.10M	-12.47M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
12.36M	14.04M	7.60M	7.51M	29.51M
	Total Assets
42.66M	40.69M	31.19M	23.99M	44.11M
	Total Debt
0.00	206.02K	588.34K	1.10M	1.81M
	Net Debt
-12.36M	-13.83M	-7.01M	-6.41M	-27.71M
	Total Liabilities
8.46M	7.00M	3.33M	3.36M	5.47M
	Stockholders Equity
34.20M	33.69M	27.86M	20.63M	38.64M
Cash Flow		Free Cash Flow
-16.52M	-20.39M	-20.64M	-17.14M	-13.67M
	Operating Cash Flow
-16.52M	-20.39M	-20.64M	-17.14M	-13.67M
	Investing Cash Flow
-3.44M	-3.99M	-7.15M	-4.15M	-3.42M
	Financing Cash Flow
18.28M	30.82M	27.88M	-708.00K	40.26M

Luxbright AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.74
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LXB, the sentiment is Positive. The current price of 0.74 is below the 20-day moving average (MA) of 0.74, below the 50-day MA of 0.76, and below the 200-day MA of 0.85, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 52.51 is Neutral, neither overbought nor oversold. The STOCH value of 36.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:LXB.

Luxbright AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
S2M	61 Neutral	kr16.21M	―		―	96.10%	94.79%
Sector *	54 Neutral	$5.38B	3.40	-45.06%	3.28%	16.75%	-0.02%
QLINEA	43 Neutral	kr282.91M	―	-159.24%	―	-22.50%	76.74%
LXB	37 Underperform	kr96.24M	―	-51.52%	―	955.20%	47.31%
CLS.B	34 Underperform	kr55.46M	―	-79.12%	―	127.04%	92.31%
QLIFE	33 Underperform	kr34.83M	―		―	-63.52%	93.00%